Tin tức & Cập nhật

Atopic dermatitis linked to subsequent IBD

05 Sep 2023

Children and adults with atopic dermatitis (AD) are at risk of inflammatory bowel disease (IBD), with the risk varying by age, AD severity, and IBD subtype, according to a study.

Atopic dermatitis linked to subsequent IBD

05 Sep 2023

Infertility treatment carries increased risk of stroke hospitalization

04 Sep 2023

Women who conceive following infertility treatment appear to have a higher likelihood of stroke-related hospitalization within 12 months of delivery as compared with those who spontaneously conceive, according to a study.

Infertility treatment carries increased risk of stroke hospitalization

04 Sep 2023

Oral anticoagulation not the best bet for patients with atrial high-rate episodes

04 Sep 2023 bởi

Patients with atrial high-rate episodes (AHRE) do not seem to benefit from anticoagulation with edoxaban, which has fallen short of reducing the composite outcome of stroke, systemic embolism, or cardiovascular death, according to the results of the NOAH-AFNET* 6 trial.

Oral anticoagulation not the best bet for patients with atrial high-rate episodes

04 Sep 2023

Bổ sung vắc-xin ung thư mRNA mang lại hứa hẹn trong bệnh cảnh melanôm

03 Sep 2023 bởi

Kết quả từ nghiên cứu pha IIb KEYNOTE 942 cho thấy: Việc thêm vào mRNA-4157, một loại vắc-xin kháng nguyên ung thư mới được cá nhân hóa trong nghiên cứu, vào thuốc ức chế điểm kiểm soát miễn dịch (ICI) pembrolizumab đã cải thiện đáng kể sống còn không tái phát (RFS) ở những người bị melanôm nguy cơ cao đã phẫu thuật.

Bổ sung vắc-xin ung thư mRNA mang lại hứa hẹn trong bệnh cảnh melanôm

03 Sep 2023

At which dose does cannabis become toxic to kids?

03 Sep 2023

Ingestion of tetrahydrocannabinol (THC) from edible cannabis at ≥1.7 mg/kg can lead to significant toxicity in young children, according to a study.

At which dose does cannabis become toxic to kids?

03 Sep 2023

Recaticimab delivers promising outcomes in non-FH, mixed hyperlipidaemia

01 Sep 2023 bởi

Monotherapy with recaticimab can significantly lower low-density lipoprotein cholesterol (LDL-C) levels in patients with nonfamilial hypercholesterolemia (non-FH) and mixed hyperlipidaemia, according to data from the phase III REMAIN-1 study presented at ESC 2023.

Recaticimab delivers promising outcomes in non-FH, mixed hyperlipidaemia

01 Sep 2023

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

01 Sep 2023

Treatment with brolucizumab results in a longer interval between injections of antivascular endothelial growth factor (anti-VEGF) agents for most treatment-experienced eyes, especially those with shorter intervals before switching, while maintaining or improving visual acuity (VA), reports a study.

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

01 Sep 2023

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

01 Sep 2023 bởi

Treatment with dexamethasone implant results in better outcomes for patients with persistent or recurrent uveitic macular edema (ME) at 12 weeks when compared with methotrexate or ranibizumab, a study has shown. The risk of intraocular pressure (IOP), however, is higher with dexamethasone, but elevations to levels of 30 mm Hg or more are rare.

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

01 Sep 2023

Ribociclib có thể có vai trò trong điều trị ung thư vú giai đoạn sớm

01 Sep 2023 bởi

Trong phân tích tạm thời thứ hai về hiệu quả của thử nghiệm pha III NATALEE, phác đồ kết hợp bao gồm thuốc ức chế CDK4/6 ribociclib và liệu pháp nội tiết (ET) đã cho thấy các dấu hiệu tich trong điều trị hỗ trợ đối với bệnh nhân ung thư vú giai đoạn sớm II/III có thụ thể nội tiết dương tính, HER2 âm tính (HR+, HER2–).

Ribociclib có thể có vai trò trong điều trị ung thư vú giai đoạn sớm

01 Sep 2023

Original New Drug Application Approvals by US FDA (16-31 August 2023)

01 Sep 2023

New drug applications approved by US FDA as of 16-31 August 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 August 2023)

01 Sep 2023

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Atopic dermatitis linked to subsequent IBD

Atopic dermatitis linked to subsequent IBD

Infertility treatment carries increased risk of stroke hospitalization

Infertility treatment carries increased risk of stroke hospitalization

Oral anticoagulation not the best bet for patients with atrial high-rate episodes

Oral anticoagulation not the best bet for patients with atrial high-rate episodes

Bổ sung vắc-xin ung thư mRNA mang lại hứa hẹn trong bệnh cảnh melanôm

Bổ sung vắc-xin ung thư mRNA mang lại hứa hẹn trong bệnh cảnh melanôm

At which dose does cannabis become toxic to kids?

At which dose does cannabis become toxic to kids?

Recaticimab delivers promising outcomes in non-FH, mixed hyperlipidaemia

Recaticimab delivers promising outcomes in non-FH, mixed hyperlipidaemia

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

Brolucizumab prolongs interval of anti-VEGF injections in nAMD patients

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

Dexamethasone superior to ranibizumab, methotrexate for recurrent uveitic ME

Ribociclib có thể có vai trò trong điều trị ung thư vú giai đoạn sớm

Ribociclib có thể có vai trò trong điều trị ung thư vú giai đoạn sớm

Original New Drug Application Approvals by US FDA (16-31 August 2023)

Original New Drug Application Approvals by US FDA (16-31 August 2023)